MIR22HG and acute myeloid leukemia: For instance, in acute myeloid leukemia (AML), XBP1s was shown to transcriptionally upregulate miR-22-3p by directly targeting its host gene, MIR22HG, leading to downregulation of SIRT1 and increased chemosensitivity [36].